readthroughSign in
CompanyCNTBNasdaqSan Diego, CA

Connect Biopharma Holdings Ltd

Connect Biopharma is a clinical-stage company developing rademikibart, an antibody targeting IL-4Rα for acute exacerbations of asthma and COPD.

SCHEDULE 13G/ANov 16Latest SEC filing
Nov 16Latest story